{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:16:22Z","timestamp":1792725382333,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ab.2023.115287","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T01:54:07Z","timestamp":1692150847000},"page":"115287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Tissue re-distribution of budesonide in rats co-administrated with curcumin by ultra performance liquid chromatography-tandem mass spectrometry"],"prefix":"10.1016","volume":"679","author":[{"given":"Tianyang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ab.2023.115287_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn's disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"9","key":"10.1016\/j.ab.2023.115287_bib2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/jgh.14151","article-title":"Oral budesonide in gastrointestinal and liver disease: a practical guide for the clinician","volume":"33","author":"Miehlke","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.ab.2023.115287_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0162-3109(97)00090-8","article-title":"Immunosuppressive effect of budesonide on human lamina propria lymphocytes","volume":"38","author":"Elitsur","year":"1998","journal-title":"Immunopharmacology"},{"issue":"5","key":"10.1016\/j.ab.2023.115287_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1398-9995.1995.tb01169.x","article-title":"Effects of \"systemic\" budesonide concentrations on in vitro allergen-induced activation of blood mononuclear cells isolated from asthmatic patients","volume":"50","author":"Oddera","year":"1995","journal-title":"Allergy"},{"key":"10.1016\/j.ab.2023.115287_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0928-0987(97)00082-1","article-title":"Binding kinetics of budesonide to the human glucocorticoid receptor","volume":"6","author":"Esmailpour","year":"1998","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"7","key":"10.1016\/j.ab.2023.115287_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1155\/1990\/708916","article-title":"Overview of newer glucocorticosteroid preparations for inflammatory bowel disease","volume":"4","year":"1990","journal-title":"Can. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.ab.2023.115287_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1517\/17425250903124355","article-title":"Budesonide for Crohn's disease","volume":"5","author":"Seow","year":"2009","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.ab.2023.115287_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.691480","article-title":"Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice","volume":"12","author":"Bruscoli","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ab.2023.115287_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2036.2001.00910.x","article-title":"Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn's disease","volume":"15","author":"Lundin","year":"2001","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.ab.2023.115287_bib10","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1046\/j.1365-2036.2002.01289.x","article-title":"The effectiveness of budesonide therapy for Crohn's disease","volume":"16","author":"Kane","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.ab.2023.115287_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ejps.2012.04.005","article-title":"Differentiating mucosal and hepatic metabolism of budesonide by local pretreatment with increasing doses of ketoconazole in the proximal jejunum","volume":"46","author":"Seideg\u00e5rd","year":"2012","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ab.2023.115287_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijpharm.2018.11.019","article-title":"Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice","volume":"554","author":"Gareb","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ab.2023.115287_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1067\/mcp.2000.106895","article-title":"Reduction of the inhibitory effect of ketoconazole on budesonide pharmacokinetics by separation of their time of administration","volume":"68","author":"Seideg\u00e5rd","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.ab.2023.115287_bib14","first-page":"461","article-title":"Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulations","volume":"64","author":"Seideg\u00e5rd","year":"2009","journal-title":"Pharmazie"},{"issue":"4","key":"10.1016\/j.ab.2023.115287_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expet Opin. Drug Saf."},{"issue":"Issue 1","key":"10.1016\/j.ab.2023.115287_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00054725-200102000-00011","article-title":"Controversies in IBD section editor, is budesonide an advance in the treatment of Crohn's disease?","volume":"7","author":"van Deventer","year":"2001","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.ab.2023.115287_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaci.2008.12.023","article-title":"Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects","volume":"123","author":"Mainardi","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.ab.2023.115287_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/biof.1716","article-title":"Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review","volume":"47","author":"Memarzia","year":"2021","journal-title":"Biofactors"},{"issue":"8","key":"10.1016\/j.ab.2023.115287_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/MCG.0000000000001416","article-title":"Novel bioenhanced curcumin with mesalamine for induction of clinical and endoscopic remission in mild-to-moderate ulcerative colitis: a randomized double-blind placebo-controlled pilot study","volume":"55","author":"Banerjee","year":"2021","journal-title":"J. Clin. Gastroenterol."},{"issue":"1\u20132","key":"10.1016\/j.ab.2023.115287_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2010.08.015","article-title":"Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin","volume":"399","author":"Yan","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ab.2023.115287_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/13880209.2020.1764060","article-title":"Effects of curcumin on the pharmacokinetics of amlodipine in rats and its potential mechanism","volume":"58","author":"Jiang","year":"2020","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ab.2023.115287_bib22","series-title":"Effects of Curcumin on the Pharmacokinetics of Loratadine in Rats: Possible Role of CYP3A4 and P-Glycoprotein Inhibition by Curcumin. Biomolecules and Therapeutics","author":"Li","year":"2011"},{"issue":"1","key":"10.1016\/j.ab.2023.115287_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/dmd.106.011072","article-title":"Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats","volume":"35","author":"Zhang","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ab.2023.115287_bib24a","unstructured":"US Department of Health and Human Services, Food and drug administration, Center for Drug Evaluation and Research and Center for Veterinary Medicine. Guidance for Industry: Bioanalytical Method Validation. Available online: https:\/\/www. fda. gov\/downloads\/drugs\/guidances\/ucm070107.pdf (accessed on 1 October 2020)."},{"key":"10.1016\/j.ab.2023.115287_bib24b","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.573118","article-title":"Pharmacokinetics and pharmacodynamics of the combination of rhein and curcumin in the treatment of chronic kidney disease in rats","volume":"11","author":"He","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ab.2023.115287_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jpba.2018.12.036","article-title":"UPLC-MS\/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma","volume":"166","author":"Xu","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ab.2023.115287_bib26","article-title":"In vivo pharmacokinetic drug-drug interaction studies between fedratinib and antifungal agents based on a newly developed and validated UPLC\/MS-MS method","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.ab.2023.115287_bib27","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s10620-005-3032-8","article-title":"Curcumin therapy in inflammatory bowel disease: a pilot study","volume":"50","author":"Holt","year":"2005","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.ab.2023.115287_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00365520802449302","article-title":"Curcumin reverses attenuated carbachol-induced contraction of the colon in a rat model of colitis","volume":"44","author":"Lubbad","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ab.2023.115287_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpba.2019.04.033","article-title":"Simultaneous determination of curcumin, tetrahydrocurcumin, quercetin, and paeoniflorin by UHPLC-MS\/MS in rat plasma and its application to a pharmacokinetic study","volume":"172","author":"Yu","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.ab.2023.115287_bib30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jpba.2006.05.016","article-title":"Detection of budesonide in human urine after inhalation by liquid chromatography-mass spectrometry","volume":"42","author":"Deventer","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ab.2023.115287_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jchromb.2014.08.009","article-title":"A validated LC-MS\/MS method for quantitative analysis of curcumin in mouse plasma and brain tissue and its application in pharmacokinetic and brain distribution studies","volume":"969","author":"Ramalingam","year":"2014","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"9","key":"10.1016\/j.ab.2023.115287_bib32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1080\/17425255.2017.1360279","article-title":"Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions","volume":"13","author":"Adiwidjaja","year":"2017","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"7","key":"10.1016\/j.ab.2023.115287_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00228-007-0298-0","article-title":"Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers","volume":"63","author":"Juan","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ab.2023.115287_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1124\/dmd.112.046318","article-title":"Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes","volume":"41","author":"Moore","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.ab.2023.115287_bib35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1124\/jpet.102.038208","article-title":"Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells","volume":"304","author":"Hukkanen","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"8","key":"10.1016\/j.ab.2023.115287_bib36","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11095-006-9041-2","article-title":"Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model","volume":"23","author":"Cao","year":"2006","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ab.2023.115287_bib37","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1038\/srep06587","article-title":"Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies","volume":"4","author":"Hsieh","year":"2014","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ab.2023.115287_bib38","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.3390\/pharmaceutics13122102","article-title":"Biomedical applications and bioavailability of curcumin-an updated overview","volume":"13","author":"Sohn","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ab.2023.115287_bib39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3892\/etm.2014.1717","article-title":"Piperine potentiates the hypocholesterolemic effect of curcumin in rats fed on a high fat diet","volume":"8","author":"Tu","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.ab.2023.115287_bib40","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-07-2693","article-title":"Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects","volume":"17","author":"Vareed","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"2","key":"10.1016\/j.ab.2023.115287_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/bdd.2346","article-title":"Regional distributions of curcumin and tetrahydrocurcumin in the liver and small intestine of rats when orally co-administered with quercetin and paeoniflorin","volume":"44","author":"Yu","year":"2023","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ab.2023.115287_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpba.2019.04.033","article-title":"Simultaneous determination of curcumin, tetrahydrocurcumin, quercetin, and paeoniflorin by UHPLC-MS\/MS in rat plasma and its application to a pharmacokinetic study","volume":"172","author":"Yu","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.ab.2023.115287_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0300-483X(80)90122-5","article-title":"Absorption and tissue distribution of curcumin in rats","volume":"16","author":"Ravindranath","year":"1980","journal-title":"Toxicology"},{"issue":"14","key":"10.1016\/j.ab.2023.115287_bib44","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.3390\/molecules27144482","article-title":"Kinetic characteristics of curcumin and germacrone in rat and human liver microsomes: involvement of CYP enzymes","volume":"27","author":"Su","year":"2022","journal-title":"Molecules"},{"issue":"4\u20135","key":"10.1016\/j.ab.2023.115287_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejps.2008.12.007","article-title":"PXR-mediated induction of human CYP3A4 and mouse Cyp3a11 by the glucocorticoid budesonide","volume":"36","author":"Zimmermann","year":"2009","journal-title":"Eur. J. Pharmaceut. Sci."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000326972300252X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000326972300252X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:40:04Z","timestamp":1757713204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000326972300252X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":46,"alternative-id":["S000326972300252X"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2023.115287","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue re-distribution of budesonide in rats co-administrated with curcumin by ultra performance liquid chromatography-tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2023.115287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115287"}}